NR1H4 and metabolic dysfunction-associated steatotic liver disease: Recently, in VPA-induced NAFLD model in mice, both oxidative stress and steatogenic effect were reversed by the administration of obeticholic acid (OCA), a farnesoid X receptor (FXR) activator [168].